STM
Journals

STM Journals Special Issues

Be at the Forefront of Research: Submit to Our Special Issues!

Drive Discovery and Advance Your Field

We're excited to announce a selection of cutting-edge Special Issues across various disciplines! These focused collections present a unique opportunity for researchers to contribute to the latest advancements and gain significant exposure within their fields.

Explore Current Research Trends

Browse our dynamic list of Special Issues below. Each topic features a detailed description highlighting its relevance and outlining the scope of research we encourage.

Benefits of Publishing in a Special Issue:

  • Targeted Audience: Reach a community of researchers specifically interested in your area of expertise.
  • Increased Visibility: Gain wider recognition with dedicated promotion of the Special Issue.
  • Fast-Track Review: Benefit from expedited peer-review processes for timely publication.
  • Lasting Impact: Contribute to a focused collection that becomes a valuable resource for future research.

Search For Topics

Topic search
Submit Manuscript
Login/Signup
Join Us
Submit Topic
Propose Conferences

Innovation, Research, and Progress: Read Our Leading Journals Now!
Journals

Connect with Peers and Establish Your Academic Presence: Use Our Profile ID!
APID

Where Ideas Meet Action: Attend Our Innovative Conferences!
STM Conferences

The Key to Your Success: Our Dynamic and Engaging Training Programs!
Training Programs

The Ultimate Platform for Aspiring Authors: Submit Your Manuscript Today!
Manuscript engine






 Special Issue Topics

—
Open Access
Special Issue
Topic

Thrombosis in COVID‐19 patients

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Thrombosis in COVID‐19 patients under section rrjooh, rrjooh in (rrjooh, rrjooh)]

        Special Issue Description

        Covid sickness 2019 (COVID-19) habitually brings about a hypercoagulable expression that is unequivocally connected with mortality. Microvascular and macrovascular thromboembolic or in situ thrombotic complexities have been seen in COVID-19 in the vasculature of the lungs, spleen, cerebrum, stomach, and periphery. There are reports of regular clots development in hemodialysis circuits, strokes as an introducing highlight in youthful patients who were beforehand sound, and blood vessel and venous thromboembolism arrangement notwithstanding prophylactic or completely helpful anticoagulation. Besides, thromboses have been recognized both in the intense setting and soon after basic sickness, recommending that the favorable to the thrombotic state could most recent a little while or significantly longer post-hospitalization. Comparable thrombotic entanglements were seen in severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Numerous patients with COVID-19 have given intense ischemic stroke or experienced a stroke while hospitalized, including youthful patients under 50 years of age with generally hardly any previous gamble factors. The rate of stroke in ICU patients has been roughly 2.5% in a few COVID-19 cohorts. Mesenteric ischemia, peripheral artery obstruction, and enormous vessel arteriosclerosis obliterans have likewise been reported, as has cerebral venous sinus thrombosis. Thrombotic complications are successive in COVID-19 and altogether add to mortality and horribleness. As Pulmonary Embolism (PE) has been generally seen in a few examination series, the event of intense PE might make sense of certain instances of unexpected right ventricular dysfunction cardiogenic shock, and abrupt demise notwithstanding troponin rise. Whether long-haul complications, for example, aspiratory hypertension might entangle present COVID recuperation stays to be seen. A few thrombogenic systems are possibly ensnared in COVID-19 apoplexy, including apoplexy set off by cytokine storm, antiphospholipid immune response disorder, macrophage activation syndrome, supplement outpouring, and RAS dysregulation.

        Editor Keywords

        COVID-19, Mortality, Thrombotic, Severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome (MERS), Cardiogenic Shock, Pulmonary Embolism (PE)

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        Research & Reviews: Journal of Oncology and Hematology, Research & Reviews: Journal of Oncology and Hematology

        Abbrivation

        rrjooh, rrjooh

        ISSN

        2319-3387, 2319-3387

        Since

        2012

        APC

        950  $